Dermatological Sequelae of COVID-19 Infection

Dudani, Pankhuri; Gupta, Vishal; Verma, Kaushal K.

doi:10.1007/978-981-19-4407-9_12

Cited by 1 publication

(1 citation statement)

References 43 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It may contribute to the lack of diagnosis of hyperinfection the similarity of some signs and symptoms in the post-COVID-19 period and in the long COVID syndrome, especially in more moderate cases. Among the coincident and most pointed symptoms for the post-COVID-19 or long-term illness period are fatigue, dyspnea, cough, fever, nausea, and digestive disorders (BANDA et al, 2020;LOPEZ-LEON et al, 2021;DESAI et al, 2022;BOGARIU & DUMITRASCO, 2022), in addition to erythema, skin rash and pruritus (CONFORTI et al, 2020;Dudani et al, 2022;MASSOD et al, 2022).…”

Section: Discussionmentioning

confidence: 99%

Steroid therapy in COVID-19 as a triggering factor for Strongyloides stercoralis hyperinfection

Norberg,

Manhães

et al. 2023

View full text Add to dashboard Cite

Strongyloides stercoralis is a nematode with worldwide geographical distribution, most frequent in tropical areas, especially prevalent in areas with poor sanitary conditions. The disease caused by S. stercoralis is known as strongyloidiasis and parasitism is usually asymptomatic. Infection by this nematode may, however, present severe symptoms in hosts with immune system deficiencies. The aim of this research is to investigate, through a review of current scientific literature, the treatment of severe COVID-19 with immunosuppressants as a triggering factor for Strongyloides stercoralis hyperinfection. There are scarce records in the scientific literature on Strongyloides stercoralis hyperinfection consequent to treatment of COVID-19 with steroid drugs, mainly in endemic areas. We believe that this complication may be highly underestimated. The finding of eosinophilia in the blood count of patients after receiving immunosuppressive therapy during COVID-19 corticoid treatment is an important marker for the possibility of Strongyloides stercoralis hyperinfection and should prompt laboratory studies for nematode screening, mainly serology and PCR.

show abstract

Section: Discussionmentioning

confidence: 99%

Steroid therapy in COVID-19 as a triggering factor for Strongyloides stercoralis hyperinfection

Norberg,

Manhães

et al. 2023

View full text Add to dashboard Cite

show abstract

Dermatological Sequelae of COVID-19 Infection

Cited by 1 publication

References 43 publications

Steroid therapy in COVID-19 as a triggering factor for Strongyloides stercoralis hyperinfection

Steroid therapy in COVID-19 as a triggering factor for Strongyloides stercoralis hyperinfection

Contact Info

Product

Resources

About